Log In
Print
BCIQ
Print
Print this Print this
 

IBI-10090

  Manage Alerts
Collapse Summary General Information
Company Icon Bioscience Inc.
DescriptionSustained-release formulation of dexamethasone delivered using Verisome technology
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationCataract
Indication DetailsReduce inflammation after cataract surgery
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today